Table 5.

Adverse events (AEs) occurring in ≥2% of patients^*

AEs	Doxazosin GITS (n = 82)	Tamsulosin (n = 83)
Number of patients with events, n (%)	17 (21)	22 (27)
Dizziness	3 (3.7)	2 (2.4)
Headache	3 (3.7)	2 (2.4)
Abnormal ejaculation	2 (2.4)	4 (4.8)
Chest pain	2 (2.4)	1 (1.2)
Decreased libido	2 (2.4)	0
Insomnia	2 (2.4)	0
Asthenia	1 (1.2)	2 (2.4)
Flu syndrome	0	2 (2.4)
Constipation	0	2 (2.4)

^*Safety population included all patients that received at least one dose of study medication. GITS, gastrointestinal therapeutic system.